Zentalis Pharmaceuticals Inc

Atvērts

4.76 -0.42

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

3.93

Max

4.87

Galvenie mērījumi

By Trading Economics

Ienākumi

-136K

-35M

EPS

-0.503

Darbinieki

106

EBITDA

2.2M

-35M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+51.84% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 4. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-33M

261M

Iepriekšējā atvēršanas cena

5.18

Iepriekšējā slēgšanas cena

4.76

Zentalis Pharmaceuticals Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 29. jūn. 23:56 UTC

Willis Towers Watson PLC shares declined slightly in after-market trading, reflecting routine price fluctuations. The asset remains above its 20-day moving average.

2026. g. 29. jūn. 23:56 UTC

Skyworks Solutions Inc. shares are lower in after-market hours, continuing to trade below their 20-day moving average amid a trend of lower closes.

2026. g. 29. jūn. 23:52 UTC

Japan's Industrial Production Expected to Rise 1.1% in May 2026 Amidst Market Volatility and Uncertainties

2026. g. 29. jūn. 23:52 UTC

Japan's May unemployment rate holds steady at 2.5%, aligning with market expectations and reflecting labor market stability.

2026. g. 29. jūn. 23:52 UTC

Brazil's S&P Global Services PMI release on July 3, 2026, expected to show continued challenges in the services sector amid stagnant demand and rising inflation pressures.

2026. g. 29. jūn. 23:52 UTC

U.S. Initial Jobless Claims Expected at 220,000 Amid Positive Labor Market Sentiment Ahead of July Release

2026. g. 29. jūn. 23:52 UTC

U.S. JOLTs Job Openings Report Set for June 30, Forecasting 7.3 Million Positions Amid Optimistic Employment Growth Sentiment

2026. g. 29. jūn. 23:52 UTC

ECB Forum on Central Banking to Address Interest Rate Policies Amid Cautious Investor Sentiment and Geopolitical Tensions

2026. g. 29. jūn. 23:52 UTC

Social Media

Microsoft shares are higher in after-market trading amid strong interest in cloud and AI infrastructure, despite a legal challenge over copyright infringement.

2026. g. 29. jūn. 23:51 UTC

U.S. equity markets show mixed performance amid cautious optimism from U.S.-Iran talks and anticipation of key economic data, including Non-Farm Payrolls.

2026. g. 29. jūn. 23:51 UTC

Global equity markets show mixed performance as Asian indices rise on easing U.S.-Iran tensions, while European stocks decline ahead of key U.S. economic data releases.

2026. g. 29. jūn. 23:51 UTC

European equity markets show mixed results amid geopolitical tensions and economic uncertainty, with improved Euro Area consumer confidence but declining UK mortgage approvals.

2026. g. 29. jūn. 23:51 UTC

Asia equity markets mixed as U.S.-Iran talks boost sentiment, while European indices decline ahead of central bank discussions.

2026. g. 29. jūn. 23:51 UTC

ETF Constituents

The Consumer Staples Select Sector SPDR Fund is higher in after-market trading, with Costco and Walmart among the top contributors to performance.

2026. g. 29. jūn. 23:51 UTC

Cognizant Technology Solutions shares are higher in after-market trading, reflecting positive sentiment from broader technology gains and recent geopolitical developments.

2026. g. 29. jūn. 23:46 UTC

United States Copper Index Fund shows modest gains in after-market trading. The asset fluctuated between a low of -1.07% and a high of 0.59%.

2026. g. 29. jūn. 23:46 UTC

T-Mobile US Inc. shares traded roughly flat in after-market hours, influenced by broader gains in technology stocks and a recovery in major averages.

2026. g. 29. jūn. 23:41 UTC

Correlated Moves
ETF Constituents

During after-market hours, GDX traded near unchanged, reflecting contributions from Newmont Corporation and Wheaton Precious Metals amid a modest rise in gold prices.

2026. g. 29. jūn. 23:41 UTC

iShares TIPS Bond ETF is lower in after-market hours, continuing a decline since Monday's close amid unusual volatility, without any specific news identified.

2026. g. 29. jūn. 23:41 UTC

Kraft Heinz Co shares are lower in after-market hours. No specific news was identified to explain the decline, despite recent higher closes.

2026. g. 29. jūn. 23:41 UTC

Macro News
Correlated Moves

Bitcoin is trading higher amid eased geopolitical tensions between the U.S. and Iran, reflecting positive sentiment in the cryptocurrency market.

2026. g. 29. jūn. 23:31 UTC

ETF Constituents

iShares MSCI Germany ETF declines after market close, impacted by EUR/USD rates and SAP's performance. The asset remains below its 20-day moving average.

2026. g. 29. jūn. 23:31 UTC

Verisk Analytics Inc shares are higher in after-market hours, reaching near the upper end of their one-month range amid cautious market optimism and geopolitical developments.

2026. g. 29. jūn. 23:31 UTC

Japan's Household Spending Report on July 6, 2026, Anticipated Amid Strong Retail Growth and Currency Concerns.

2026. g. 29. jūn. 23:31 UTC

Japan's Household Spending Report Set for July 6, Amidst Strong Retail Sales and Yen Decline Concerns.

2026. g. 29. jūn. 23:31 UTC

Shares of Fiserv Inc. are higher in after-market trading, despite earlier declines. Investor sentiment is influenced by geopolitical developments and cautious optimism in the market.

2026. g. 29. jūn. 23:31 UTC

Macro News
ETF Constituents

Energy Select Sector SPDR Fund rises after Gulfport Energy's $83 million acquisition and a decline in the U.S. Dollar Index during after-market trading.

2026. g. 29. jūn. 23:31 UTC

News
Social Media

Comcast shares are higher in after-market trading amid reports of a potential expansion into video games and plans for AI-focused data centers.

2026. g. 29. jūn. 23:26 UTC

MercadoLibre Inc. shares are trading higher in after-market hours, influenced by cautious optimism surrounding U.S.-Iran negotiations and broader market sentiment.

2026. g. 29. jūn. 23:26 UTC

Correlated Moves
ETF Constituents

Digital Realty Trust's decline led to little change in VNQ after-hours.

Salīdzinājums

Cenas izmaiņa

Zentalis Pharmaceuticals Inc Prognoze

Cenas mērķis

By TipRanks

51.84% augšup

Prognoze 12 mēnešiem

Vidējais 7 USD  51.84%

Augstākais 10 USD

Zemākais 4 USD

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Zentalis Pharmaceuticals Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

7 ratings

4

Pirkt

3

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.
help-icon Live chat